Log in
Advanced Prostate Cancer
6,018 members5,775 posts

Interesting Talk By Professor McDermott

Hi everyone.

I found this talk by Professor McDermott, who is Paul's oncologist, on the internet and wanted to share it with you.

I am very impressed with this talk. The presentation is very good. And what he has to say about the improvements in treatment of prostate cancer is very understandable. And the main message we are talking away from this talk is that the approaches to treatments should be more and more individualized and not necessarily following the common protocoll.

See what you think.


3 Replies

Hi Mel. I can’t wait to listen to this. Visiting our oldest son for Christmas & everyone is still asleep. I agree with your takeaway that ALL treatment should be individualized! I continue research, read and learn since I lost my hubby to CRPC because I am very concerned for our sons 50 & 51. Our oldest just got PSA results 2.4. GP said “no problem, that’s normal”. At my insistence he got a referral to a urologist because of his Dad & Dad’s brother both having PC and their Mom had breast cancer. He goes in 2 weeks. I am going to have him listen to this also. So thank you again for posting! All the best to your hubby in his battle against this beast and to you as caregiver. Strength and encouragement to you both!


--------> FIST BUMP <---------

j-o-h-n Sunday 12/24/2017 1:54 PM EST



Alpharadin is now called Xofigo. To note, this presentation is more than 2 years old, so there’s even more improvement in treatments and imaging techniques now. Agree that one size fits all is not the trend anymore, but ‘standard of care’ is slow to catch up.

Highly recommend the annual PCRI Conference in Los Angeles, which we attended in Sep 2017. All the presentations and Q&A sessions are videotaped, and you can purchase the DVDs for a small donation (suggested $150). We bought the 2016 conference DVDs and I watched all of them. Even though we were able to attend the 2017 event, I’m still planning to buy the DVDs, just to be able to watch key presentations again and take notes. This event was very valuable to us in understanding the risk vs benefits of various treatment options for recurrence, and having informed discussions with oncologists.



You may also like...